BMS 195614

CAS No. 253310-42-8

BMS 195614( —— )

Catalog No. M33791 CAS No. 253310-42-8

BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 397 In Stock
10MG 588 In Stock
25MG 939 In Stock
50MG 1237 In Stock
100MG 1655 In Stock
200MG Get Quote In Stock
500MG 3329 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS 195614
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
  • Description
    BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    Retinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    253310-42-8
  • Formula Weight
    448.51
  • Molecular Formula
    C29H24N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(CC=C(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)C4=CC5=CC=CC=C5N=C4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SR9009

    SR9009, a REV-ERB agonist, increases the constitutive repression of genes regulated by REV-ERBα/ERBβ (IC50: 670/800 nM).

  • KCL-286

    KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI).

  • Halofuginone

    Halofuginone, the competitive inhibitor of prolyl-tRNA synthetase(Ki=18.3 nM), could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in the mammal.